Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SRF vs TATVA CHINTAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SRF TATVA CHINTAN PHARMA SRF/
TATVA CHINTAN PHARMA
 
P/E (TTM) x 53.0 77.0 68.8% View Chart
P/BV x 7.6 5.6 134.5% View Chart
Dividend Yield % 0.3 0.2 169.3%  

Financials

 SRF   TATVA CHINTAN PHARMA
EQUITY SHARE DATA
    SRF
Mar-23
TATVA CHINTAN PHARMA
Mar-23
SRF/
TATVA CHINTAN PHARMA
5-Yr Chart
Click to enlarge
High Rs2,8642,649 108.1%   
Low Rs2,0031,606 124.7%   
Sales per share (Unadj.) Rs501.7191.1 262.5%  
Earnings per share (Unadj.) Rs72.920.5 355.5%  
Cash flow per share (Unadj.) Rs92.424.8 372.0%  
Dividends per share (Unadj.) Rs7.202.00 360.0%  
Avg Dividend yield %0.30.1 314.7%  
Book value per share (Unadj.) Rs348.0232.2 149.9%  
Shares outstanding (eoy) m296.4222.17 1,337.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.911.1 43.6%   
Avg P/E ratio x33.4103.7 32.2%  
P/CF ratio (eoy) x26.385.7 30.8%  
Price / Book Value ratio x7.09.2 76.3%  
Dividend payout %9.99.7 101.3%   
Avg Mkt Cap Rs m721,32847,157 1,529.6%   
No. of employees `000NANA-   
Total wages/salary Rs m7,692386 1,992.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m148,7034,236 3,510.3%  
Other income Rs m74957 1,304.5%   
Total revenues Rs m149,4524,294 3,480.8%   
Gross profit Rs m35,292572 6,171.0%  
Depreciation Rs m5,75396 6,021.1%   
Interest Rs m2,04886 2,381.6%   
Profit before tax Rs m28,240448 6,306.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,617-7 -93,453.4%   
Profit after tax Rs m21,623455 4,753.8%  
Gross profit margin %23.713.5 175.8%  
Effective tax rate %23.4-1.6 -1,481.9%   
Net profit margin %14.510.7 135.4%  
BALANCE SHEET DATA
Current assets Rs m57,7503,136 1,841.8%   
Current liabilities Rs m49,1662,361 2,082.1%   
Net working cap to sales %5.818.3 31.6%  
Current ratio x1.21.3 88.5%  
Inventory Days Days243 834.7%  
Debtors Days Days473 6.0%  
Net fixed assets Rs m129,6094,304 3,011.4%   
Share capital Rs m2,974222 1,341.9%   
"Free" reserves Rs m100,1804,926 2,033.6%   
Net worth Rs m103,1545,148 2,003.8%   
Long term debt Rs m23,11542 54,645.9%   
Total assets Rs m187,3597,439 2,518.5%  
Interest coverage x14.86.2 238.2%   
Debt to equity ratio x0.20 2,727.1%  
Sales to assets ratio x0.80.6 139.4%   
Return on assets %12.67.3 173.8%  
Return on equity %21.08.8 237.2%  
Return on capital %24.010.3 233.2%  
Exports to sales %17.176.2 22.5%   
Imports to sales %23.556.9 41.2%   
Exports (fob) Rs m25,4853,229 789.3%   
Imports (cif) Rs m34,8722,409 1,447.4%   
Fx inflow Rs m25,4853,229 789.3%   
Fx outflow Rs m34,8722,409 1,447.4%   
Net fx Rs m-9,387820 -1,145.2%   
CASH FLOW
From Operations Rs m29,017278 10,444.2%  
From Investments Rs m-29,614-1,011 2,927.9%  
From Financial Activity Rs m2,196378 581.0%  
Net Cashflow Rs m1,575-357 -441.8%  

Share Holding

Indian Promoters % 50.3 72.0 69.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 35.1 16.5 212.6%  
FIIs % 19.1 3.7 522.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.7 28.0 177.6%  
Shareholders   234,321 73,730 317.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SRF With:   PIDILITE INDUSTRIES    BALAJI AMINES    YASHO INDUSTRIES    GHCL    NAVIN FLUORINE    


More on SRF vs TATVA CHINTAN PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SRF vs TATVA CHINTAN PHARMA Share Price Performance

Period SRF TATVA CHINTAN PHARMA
1-Day 0.18% 0.02%
1-Month 2.31% 9.97%
1-Year 5.66% -23.68%
3-Year CAGR 28.63% -18.73%
5-Year CAGR 38.82% -11.70%

* Compound Annual Growth Rate

Here are more details on the SRF share price and the TATVA CHINTAN PHARMA share price.

Moving on to shareholding structures...

The promoters of SRF hold a 50.3% stake in the company. In case of TATVA CHINTAN PHARMA the stake stands at 72.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SRF and the shareholding pattern of TATVA CHINTAN PHARMA.

Finally, a word on dividends...

In the most recent financial year, SRF paid a dividend of Rs 7.2 per share. This amounted to a Dividend Payout ratio of 9.9%.

TATVA CHINTAN PHARMA paid Rs 2.0, and its dividend payout ratio stood at 9.7%.

You may visit here to review the dividend history of SRF, and the dividend history of TATVA CHINTAN PHARMA.

For a sector overview, read our textiles sector report.



Today's Market

Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7% Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7%(Closing)

After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.